EVANOA uses a novel proprietary technology to make order-of-magnitude improvements in cell lines used for the production of
biopharmaceuticals such as recombinant proteins, viral vaccines, gene therapies and plasmids.

Our technology and expertise applies to any cell line or industrial condition and allows our partners to increase yield, reduce extraction costs and enhance the overall process efficiency, giving them an insurmountable advantage over their competitors.